Manos Giorgakis (@manosgiorgakis) 's Twitter Profile
Manos Giorgakis

@manosgiorgakis

Associate Prof | Abdominal transplant & HPB surgeon @UNC | @MayoClinic @UCL @uoaofficial Alum

ID: 1826406317243703296

calendar_today21-08-2024 23:49:57

83 Tweet

371 Takipçi

552 Takip Edilen

Manos Giorgakis (@manosgiorgakis) 's Twitter Profile Photo

Comparable graft survival is achievable with the usage of donation after circulatory death liver grafts from donors at or above 70 years of age: A long-term UK national analysis - American Journal of Transplantation amjtransplant.org/article/S1600-… ILTS IHPBA ESOTtransplant

Manos Giorgakis (@manosgiorgakis) 's Twitter Profile Photo

#AcuityCircles allocation policy impact on waitlist mortality and #DCD liver transplantation: A nationwide retrospective analysis onlinelibrary.wiley.com/doi/10.1002/hs… ILTS

Manos Giorgakis (@manosgiorgakis) 's Twitter Profile Photo

#WaitTime Advantage for #Kidney_Transplant Candidates With #HIV Who Accept Kidneys From #HIV_positive donors Under the #HOPE_Act journals.lww.com/transplantjour… Transplantation TTS Johns Hopkins University

Homer Pavlos (@homerpavlos) 's Twitter Profile Photo

The woman is the mirror of a man's soul, for through her presence, he discovers his strength, his weakness, and his very existence. She is not merely a companion but the very breath that gives meaning to his journey. Love her, respect her and protect her. #WomensDay

The woman is the mirror of a man's soul, for through her presence, he discovers his strength, his weakness, and his very existence. She is not merely a companion but the very breath that gives meaning to his journey. 

Love her, respect her and protect her. #WomensDay
Transplantation (@transplantjrnl) 's Twitter Profile Photo

Normothermic Regional Perfusion (NRP) in circulatory determination of death (cDCDD): A Game Changer. Learn more about this innovative preservation strategy! #Transplantation #OrganDonation #TXPforAll tinyurl.com/39wnwh6d

Normothermic Regional Perfusion (NRP) in circulatory determination of death (cDCDD): A Game Changer. Learn more about this innovative preservation strategy! #Transplantation #OrganDonation #TXPforAll tinyurl.com/39wnwh6d
Paulo Martins MD, PhD, FACS (@paulo_martinsmd) 's Twitter Profile Photo

Our paper: “EXPANDING THE USE OF EX SITU ORGAN MACHINE PERFUSION BEYOND TRANSPLANTATION” is just 🔥hot off the press : There is increasing interest in utilizing machine perfusion for a variety of purposes beyond transplantation including; 1) study organ physiology, 2) ex situ

Our paper:

“EXPANDING THE USE OF EX SITU ORGAN MACHINE PERFUSION BEYOND TRANSPLANTATION” 

is just 🔥hot off the press :

There is increasing interest in utilizing machine perfusion for a variety of purposes beyond transplantation including; 1) study organ physiology, 2) ex situ
Manos Giorgakis (@manosgiorgakis) 's Twitter Profile Photo

“The mortality from the failed early trials and that which occurred later did not mean that liver transplantation was causing deaths. These patients were under a death sentence already because of the diseases that had brought them to us. Even now, I continue to receive letters

“The mortality from the failed early trials and that which occurred later did not mean that liver transplantation was causing deaths. These patients were under a death sentence already because of the diseases that had brought them to us. Even now, I continue to receive letters
Åsmund A. Fretland (@aafretland) 's Twitter Profile Photo

“Transplant oncology is chasing the highest tumor load associated with cure” Great update from Vincenzo Mazzaferro, including new data on immune responses in the transplanted liver🤩 #eahpba2025 #transplantoncology

“Transplant oncology is chasing the highest tumor load associated with cure” 
Great update from Vincenzo Mazzaferro, including new data on immune responses in the transplanted liver🤩 #eahpba2025 #transplantoncology
CA: A Cancer Journal for Clinicians (@cacancerjournal) 's Twitter Profile Photo

🚨 Don't miss this timely review on hepatocellular carcinoma! Evolving treatments—including surgery, locoregional therapy & immunotherapy—may offer curative options for advanced disease. Explore the article: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… Michael Lidsky, MD, FACS Dimitrios Moris MD, MSc, PhD OncoAlert

🚨 Don't miss this timely review on hepatocellular carcinoma! Evolving treatments—including surgery, locoregional therapy & immunotherapy—may offer curative options for advanced disease.

Explore the article: 
acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

<a href="/michael_lidsky/">Michael Lidsky, MD, FACS</a> <a href="/DimitriosMoris/">Dimitrios Moris MD, MSc, PhD</a> <a href="/OncoAlert/">OncoAlert</a>